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Aim: To assess tobacco use and some characteristics of tobacco users (including electronic
cigarette users) relevant to cardiovascular disease in a representative population sample of
the city of Brno.
Methods: A cross-sectional survey of cardiovascular risk factors was conducted using the
methodology of the Czech post-MONICA Study, in the city of Brno, Czech Republic in 2013.
This preliminary report of the ﬁrst 965 randomly selected volunteers (including 512 women)
aged 25–64, focuses on tobacco use, its prevalence in different subgroups as well as on the
attitudes towards smoke-free policies.
Results: This preliminary analysis involves 965 individuals with a mean age of 47.3  11.40
years. The prevalence of smoking was 26.7%, with daily tobacco use 23.3%, less than once
daily 3.4%; 19.9% of the sample are ex-smokers. A total of 34.0% of the survey population
reported exposure to passive smoking. Electronic cigarette use was observed in 3.5% of
respondents, more common in men (5.1%) than in women (2.1%; p = 0.020). Concomitant use
of electronic cigarettes and smoking was observed in 2.07% of the population.
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Conclusion: The prevalence of tobacco use in the productive-age population of Brno City
district is 26.70%, still a high ﬁgure.
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.Introduction
Tobacco use kills about 16,000 Czechs every year [1]. Smoking
increases total mortality, including cardiovascular mortality of
the population [2,3]. Progression of atherosclerosis (measured
by intima-media thickness) is enhanced by 50% in smokers
and by 20% in passive smokers compared with those
unexposed to tobacco smoke [4,5]. Based on the results of
the INTERHEART Study conducted in 52 countries, smoking
was the cause of 36% of cases of myocardial infarction
(‘‘population-attributable risk’’) [6].
The negative impact of smoking on lipid metabolism
(increase of triglycerides, LDL cholesterol, and decrease of
HDL cholesterol) and on insulin resistance is well recognised
[7–9], as are the adverse effects of free radicals contained in
tobacco smoke, which convert especially HDL cholesterol into
proatherogenic oxidised particles [10,11].
Smoking is associated with the activation of sympathetic
nervous system and temporarily increases heart rate and
blood pressure [12].
The knowledge and awareness of a healthy lifestyle are still
different in Western Europe and Eastern Europe [13], and the
decrease in smoking prevalence witnessed in Western Europe
have not been documented in the Czech Republic to date [14].
The Czech MONICA and Czech Post-MONICA surveys
described a signiﬁcant decrease in tobacco use in men (from
45.0% to 30.5%), but not in women (average of 23.9% over the
surveyed period report between 1985 and 2007/8) [15]. Over the
same time period, the BMI in men increased, while that in
women remained unchanged.
These data have to be compared with those collected by the
National Institute of Public Health in Prague monitoring
tobacco use in the Czech Republic on a regular basis. The
prevalence of smoking in 2011 was 29.1%, a ﬁgure about the
same throughout the last 15 years. The only difference was
observed in 1999 and 2002, when the number of daily smokers
approached 20%, whereas the number of occasional smokers
increased [16].
A study named Use of Tobacco and Alcohol in the Czech
Republic in 2012, published (again by the Prague-based
National Institute of Public Health) in 2013 reported an overall
smoking prevalence of 31.3% (36.5% in men, and 26.3% in
women). The highest prevalence of tobacco use, 43.4%, was
observed among those aged 15–24 years, with the prevalence
declining to 33.3% among the 25–44-year olds, and 28.7% in the
generation of 45–64 years old. The lowest prevalence of 20.5%
was documented in the 65+ population [16]. The highest
prevalence in the youngest generation is supported by other
ﬁndings, including the prevalence of smoking among 15-year-
old girls and boys in Brno [17], being 33% in 2011.
An analysis of the data collected from 2003 in the Czech
Health and Life Style Study was published by Spilková et al.[18]. The study also had an impressive sample size of 3526
persons aged 18–64 years at the time of the survey, with an
overall smoking prevalence of 37.3% (44.9% in men and 29.7%
in women). The authors also reported the highest smoking
rates (44.0%) in the youngest generation (18–29 years), followed
by the 30–39-year olds with a smoking prevalence of 37.60%,
with the prevalence again rising to 41.00% among those aged
40–49. The lowest smoking prevalence was reported for the
population aged 50–64 (27.9%).
Another project conducted jointly with the National
Institute of Public Health was a cross-sectional survey of the
HAPIEE Study [19] documenting a smoking rates of 31.9% and
26.3% among Czech men and women, respectively (data for
2050 men with a mean age of 56.6  7.2 years and 2452 women
with a mean age of 55.8  7.0 years). The average BMI was 27.5
 3.6 in men, and 26.9  4.5 in women.
As a new phenomenon, the e-cigarette has been marketed
in the Czech Republic since 2006, and are sold legally, both in
shops or via the Internet. About one half of Czech smokers
have tried them, and about one in ﬁve smokers who have had a
try use them repeatedly. The majority of e-cigarette users
(60%) report they have helped them to reduce smoking
intensity [20]. Use of the e-cigarette in the Czech Republic
seems to be higher than in other countries [21].
There are no data about tobacco use in the Brno population
available since 1997 [22]. Less is also known about the
prevalence of use and effects of the e-cigarette. Likewise,
there are no data from cross-sectional surveys conducted in
the Czech Republic designed for biochemical validation of
exhaled carbon monoxide. Therefore, the aim of this analysis
is to report on tobacco use and to analyse some characteristics
of tobacco users.
Methods
Population
The primary aim of the ﬁrst phase of Kardiovize Brno 2030 is to
assess the prevalence of major cardiovascular risk factors in
the population of Brno City district in a random sample of 2000
volunteers aged 25–64 using the methodology of the Czech
post-MONICA study [15,23].
The state-run General Health Insurance Company (keeping,
by law, a registry of all individuals insured with all Czech
health insurance companies) randomly selected a representa-
tive sample 3600 insurees aged 25–64 years, permanent
residents of Brno City district. According to data released by
the Czech Statistical Ofﬁce, the city of Brno had a population of
373,327 as of 1st January 2013) [24], our goal was to enroll a
representative sample of 2000 volunteers corresponding to
about 1% population sample aged 25–64 years. Since January
31, 2013, a total of 965 participants registered with of the two
Fig. 1 – Factors preventing smokers from quitting (N = 258).
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Insurance Company and Health Insurance Company of the
Interior Ministry of the Czech Republic) were enrolled until 2nd
October 2013, with enrollment still ongoing.
Using validated questionnaires, the following information
and data were collected during the baseline interview:
demographic data, medical and family histories, dietary
habits, extent of physical activity, smoking status, alcohol
consumption, and data on socioeconomic factors.
All anthropometric and body composition measurements
were performed by trained personnel according to the study
protocol. Participants wore only underwear while measured.
Height was measured without shoes using a professional SECA
stadiometer, with the head positioned in the Frankfort
horizontal plane, and weighed without shoes using a
calibrated professional high-precision SECA ﬂoor scale; with
the value rounded to the nearest 0.1 kg.
Lipids and lipoprotein analyses were performed by the
Modular SWA P300 analyser (Roche, Basel, Switzerland) with
commercially available kits: total cholesterol and triglycerides
were assayed by the enzymatic colorimetric method (Roche
Diagnostic GmbH), HDL-cholesterol by the homogeneous
method for direct measuring without precipitation (Sekisui
Medical, Tokyo, Japan). Apolipoprotein A was determined by
immunoturbidimetric assay (Roche Diagnostic GmbH). LDL-
cholesterol was calculated according to the Friedewald
equation: LDL-C = TC  (HDL-C + TG/2.19).
Body fat percentage was measured using the InBody 370
device (Biospace, Seoul, South Korea).
Dependence on nicotine was assessed by the Fagerström
Test of Cigarette Dependence [25,26]. This test consists of 6
questions with an overall score ranging between 0 and 10 points.
Smoking status was veriﬁed by measuring carbon monoxide
[measured in parts per million (ppm)] in expired air by a carbon
monoxide analyser Micro+ Smokerlyzer (Bedfont, UK) [27].
A daily smoker was deﬁned as a smoker of at least one
cigarette daily or having exhaled 10 ppm of carbon monox-
ide. Occasional smokers were deﬁned as anyone smoking less
than once daily during the last 12 months. Ex-smokers were
deﬁned as anyone who smoked more than 100 cigarettes in
their life, but not a single cigarette during the last 12 months.
Readiness to quit was assessed using the Readiness to quit
ladder [source: Mayo Clinic Nicotine Dependency Center (CRF
1), courtesy of Ivana Croghan M.D., Ph.D.], a 6-item ladder
validated and used worldwide for assessment of motivation.
In addition, quit attempts and barriers to quitting were
assessed using a special questionnaire (for questions, see
Fig. 1).
Of the 966 volunteers, data were analysed for 965 individuals
including 453 men (46.9%): one participant refused to continue
and withdrew their informed consent. The study was approved
by the Institutional Review Board (IRB) on October 10, 2012.
Statistical analysis was performed using JMP 9 and
Statistica 12 software. The data were analysed descriptively
and compared between the groups. Standard measures of
summary statistics were used to describe the primary data:
relative and absolute frequencies for categorical variables,
arithmetic mean supplied with standard deviation for contin-
uous variables. The chi-square test was used to compare the
groups in categorical data. Continuous parameters of thegroups were compared using ANOVA or the nonparametric
Kruskal–Wallis test (depending on data distribution).
Results with a p-value < 0.05 are considered statistically
signiﬁcant.
Results
A total of 965 individuals were included into this preliminary
analysis. The mean age of respondents was 47.3  11.40 years.
Smoking prevalence was 26.7%, daily smokers comprise 23.3%
of the population, there are 3.4% of occasional smokers
(deﬁned as those smoking less than once daily), and 19.9%
of ex-smokers (for details, see Table 1). Daily cigarette use was
more common in men (26.3%) than in women (20.7%;
p = 0.047). If evaluated by age groups, the highest tobacco
daily use was documented among those 55–64-year old (30.8%
of the sample in the same age group), while being lowest
among those aged 35–44 (with smokers making up only 21.7%
of all participants of this age group) (for details, see Table 2).
Waterpipe use was prevalent in 0.5% (4 participants). Other
tobacco products (except for cigarettes but including water-
pipe, cigars, pipe) were used in 1.3%.
Of note, 15 of the responders declared themselves to be
non-smokers or ex-smokers, but their breath analysis showed
values over 10 ppm (and thus had to be counted as smokers).
Use of cigarettes by education level
As expected, non-smoking volunteers were more frequently
university graduates (48.9% of the whole sample of non-
smokers compared with the group of smokers, where only
26.4% held a university degree, p < 0.001). The level of high-
school education or apprenticeship without a school-leaving
exam was signiﬁcantly more common among smokers (39.9%
and 26.4%, respectively). A comparison of smokers, ex-
smokers, and non-smokers by their highest level of education
attained is in Fig. 2.
Tobacco use, lipids and selected anthropometric parameters
We observed signiﬁcantly higher levels of triglycerides in
smokers (1.36 mmol/l) and ex-smokers (1.33 mmol/l) com-
pared with non-smokers (1.20 mmol/l; p < 001) as well as
signiﬁcantly lower levels of HDL cholesterol in the group of
Table 1 – Smoking prevalence in population of Brno-city aged 25–64 in 2013.
Parameter Overall N = 965 Male N = 453 Female N = 512 p-Value
N (%) N (%) N (%)
Smokers 225 (23.3%) 119 (26.3%) 106 (20 7%) 0.047
Non-smokers 497 (51.5%) 205 (45.3%) 292 (57.0%) <0.001
Occasional smokers 33 (3.4%) 15 (3.3%) 18 (3.5%) 0.862
Ex smokers 192 (19.9%) 106 (23.4%) 86 (16.8%) 0.012
Passive smokers 319 (34.0%) 180 (41.1%) 139 (27.9%) <0.001
In the restaurant 246 (25.5%) 150 (33.1%) 96 (18.8%) <0.001
In their workplace 66 (6.8%) 45 (9.9%) 21 (4.1%) 0.135
In their home 59 (6.1%) 26 (5.7%) 33 (6.4%) 0.131
On other places 31 (3.2%) 14 (3.1%) 17 (3.3%) 0.108
Passive smokers – daily exposure 85 (8.8%) 47 (10.4%) 38 (7.4%) 0.112
Waterpipe 5 (0.5%) 4 (0.9%) 1 (0.2%) 0.812
Other tobacco products 11 (1.1%) 11 (2.4%) – <0.001
E-cigarette 34 (3.5%) 23 (5.1%) 11 (2.1%) 0.020
Concomitant use of e-cigarettes and tobacco 20 (2.07%) 12 (10.1%) 8 (7.5%) 0.503
Table 2 – Tobacco use by age groups in Brno population in 2013.
Decades Smokers N = 258 Ex-smokers N = 192 Non-smokers N = 497 p-Value2
N (%) N (%) N (%)
25–34 years (N = 159) 48 (30.2%) 24 (15.1%) 87 (54.7%) <0.001
35–44 years (N = 231) 50 (21.7%) 44 (19.1%) 137 (59.3%) <0.001
45–54 years (N = 242) 63 (26.0%) 49 (20.3%) 130 (53.7%) <0.001
55–64 years (N = 315) 97 (30.8%) 75 (23.8%) 143 (45.4%) <0.001
p-Value1 0.088 0.164 0.011
p-Value1 – tests the difference between different age decades separately for smokers/ex-smokers/non-smokers.
p-Value2 – tests the difference between smokers, ex-smokers and non-smokers in each age decade.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 1 8 – e 1 2 7 e121smokers (1.46 mmol/l) and ex-smokers (1.48 mmol/l) com-
pared with and non-smokers (1.55 mmol/l; p = 0.005). No
difference was seen in the levels of Apo A1 lipoprotein
between smokers and non-smokers. When comparing weight
and BMI in the three subgroups by their smoking status,
lifelong non-smokers had the lowest body weight (and BMI
and body fat percentage) this being led by differences in males.
The observed difference in BMI became signiﬁcant after78
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Quit attempts
The majority, 95.0% of smokers, said they had tried to quit.
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c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 1 8 – e 1 2 7e122trying to quit on an average 6.2 times (N = 136 male smokers),
and women as many as 7.8 times (N = 129 female smokers).
When analysing separately data of ex-smokers (N = 192),
their average number of quit attempts was 3.7. Female ex-
smokers (N = 86) needed only 3.3 quit attempts on average,
whereas male ex-smokers (N = 106) required 4.0 quit
attempts to be successful ( p = NS). Only one woman declared
current use of nicotine replacement therapy (NRT) 2–4 times
weekly at the time of the survey, the remaining 11 users
reported NRT use less than once monthly. Use of bupropion
or varenicline was not documented in our group. All smokers
were asked about the most common barriers to change, for
results, see Fig. 1.
Depression and smoking
Use of the PHQ-9 Questionnaire did not show any signiﬁcant
difference in the incidence of depression according to the
smoking status. The proportion of smokers experiencing
minimal depression is lower (53.9%) compared with non-
smokers (59.6%), but this difference was not signiﬁcant
( p = 0.155). On the contrary, the proportion of smokers
reported moderate depression is non-signiﬁcantly higher
(6.2%) than in the group of non-smokers (3.4%; p 0.076).
Passive smoking
Our results show exposure to tobacco smoke in 34% of the Brno
City population, more often in men (41.1%) than in women
(27.9%; p < 0.001). The bulk of passive smoking exposure
occurs in restaurants (25.5% of Brno citizens), again more often
in men than in women (33.1% and 18.8%, respectively;
p < 0.001). Daily exposure to tobacco smoke was reported by
8.8% of the Brno City population.
Marijuana use
In our sample of 965 volunteers, 15 men (3.3%) and 3 women
(0.6%) admitted to have used marijuana within the last four
weeks (self-report). We noted only 3 cases of marijuana users
without concomitant tobacco use, the remaining 12 marijuana
users were using tobacco as well.
Use of e-cigarettes
Electronic cigarette use was documented in 3.5% of respon-
dents (N = 34). Use of the electronic cigarette was more
common in men (5.1%) than in women (2.1%; p = 0.020). If
evaluated by age groups, the highest use was reported in the
45–54 year age group (33.3%), more often in men (39.1%) than in
women (20.0%), p = 0.013. The lowest use was observed in the
youngest, 25–34-year, age group (12.1%). Interestingly, use of e-
cigarettes did not differ by the average household income, but
by the level of education, with the highest level of education in
exactly 50.0% (N = 12) of e-cigarette users being apprenticeship
as against just 4 e-cigarette users (11.8%) with university
education.
Concomitant use of the e-cigarette and tobacco was
documented in 2.1% (N = 20) of the sample. The average
number of cigarettes smoked decreased in those using the e-
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c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 1 8 – e 1 2 7 e123cigarette. The number of quit attempts among e-cigarette
users (6.4  4.7) was not statistically different from the rest of
the group of smokers.
Attitude towards smoke-free policies
The attitude towards smoke-free policies in restaurants is
reﬂected in the popularity of non-smoking restaurants.
Smokers support the existence of smoke-free restaurants in
60.8%, ex-smokers in 77.6%, and non-smokers in 88.0%
( p < 0.001). By contrast, only 25.1% of smokers do not like
smoke-free restaurants compared with just 6.3% of ex-
smokers and 5.0% of non-smokers in disfavour of the
smoke-free policies in restaurants ( p < 0.001), with the
remainder to 100% being uncertain (see Table 4).
Discussion
We are not aware of any other study designed to assess the
prevalence of smoking tobacco, marijuana, and electronic
cigarettes in the city of Brno population. All population cross-
sectional surveys of smoking prevalence in the Czech Republic
have to date been based on self-reporting only [15,16,28], and
only a limited number of studies conducted in the Czech
Republic [29–33] used biochemical validation of exhaled
carbon monoxide.
Our study allows to compare the prevalence of tobacco
exposure in the Brno population in 2013 with results of the
Czech post-MONICA Study dating back to 2006–2009 [23]. Our
study employed the same methodology and age range (25–64-
year-old volunteers). The Czech post-MONICA investigators
reported smoking in 31.9% of men and 23.3% of women in
2006–2009, with the proportion of occasional smokers being
3.3% in men and 3.9% in women. While the number of
occasional smokers remains unchanged, the number of daily
smokers is lower in Brno (total 26.7% of smokers). In our
sample, we identiﬁed 15 volunteers declaring to be non-
smokers; however, their levels of exhaled carbon monoxide
were equal to or higher than 10 ppm (implying higher
exposure to tobacco smoke as compared with a passive
smoker). One could speculate about the true number of
smokers in the previous cross-sectional survey of Czech post-
MONICA based as it was solely on self-reporting. Therefore,
the smoking rates in the Czech post-MONICA study are slightly
under-reported. The prevalence of smoking based on regular
surveys conducted by the National Institute of Public Health
remains constant and the data obtained in 1997 are consistent
with results reported in 2011 [28]. This survey did not
demonstrate a signiﬁcant trend of this prevalence or an
increase in the number of quit attempts. The authors would
rather expect a lower prevalence tobacco use in the sample of
volunteers (willing to come, sign the informed consent, and
have the examination).
The authors ﬁnd the above results somewhat surprising
and conﬁrming older results reported from the Brno area [23]
(Proﬁl zdraví města Brna) in 1997, where the highest proportion
of daily smokers also belonged to the 40–59-year age group
(32.91%), compared with the lowest prevalence in the youngest
Fig. 3 – Readiness to quit ladder (N = 258).
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 1 8 – e 1 2 7e124population aged 18–24 (16.67%). However, the latter age group
had a (‘‘compensatory’’) high prevalence of occasional
smokers (25.93%) as well as those aged 25–39 with 13.18% of
occasional smokers.
As in other countries, the popularity of the electronic
cigarette, or the e-cigarette, a form of electronic nicotine
delivery systems (ENDS) [34] has been on the increase in the
Czech Republic. The main advantages may include the
absence of ﬁre and thus thousands of chemicals, no butts
and smoke, and none or close to zero risk of passive smoking.
The nicotine from e-cigarettes may be more attractive to
smokers than the current forms of NRT [35].
Overall, e-cigarettes are a controversial issue with varied
regulation in various countries, from a ban in Panama [36] to
regulation as a tobacco product in the Czech Republic [37]. A
proposal put forth as part of a EU tobacco control directive to a
form of NRT was refused on 10 December 2013 by the European
Parliament in the Revision of the Tobacco Products Directive
[38]. The e-cigarette is currently considered a form of NRT in
Hong Kong [39]. There are not enough studies demonstrating
its safety, even if the cancerogenic formaldehydes or nicoti-
namides as well as toxins in different liquids in the e-
cigarettes are at concentrations 9–450 times lower compared
with those measured in cigarette smoke [40].
Interestingly, in our sample, the prevalence of e-cigarette
use is higher among individuals of the age group of 45–54
(more than in younger population). Despite their age, they did
not report a higher number of previous quit attempts.
Likewise, the highest level of education attained by the
majority of e-cigarette users was apprenticeship without a
school-leaving examination. One can only speculate the
smokers have a lower medical literacy level, may have be
already motivated by some health limitations related to
smoking, but are most likely reluctant to seek medical help.
The total of 2.07% of the surveyed population admitting
tobacco smoking and e-cigarette use conﬁrms previous data
from research by Etter and Bullen showing that e-cigarettes are
widely used as a tool for harm reduction [41–43]. The use of the
e-cigarette is often complementary to continued tobacco
smoking as an ‘‘accessory’’ only (allowing to smoke in
smoke-free areas such as stadiums or restaurants) rather
than an aid to quit. However, recent data from randomised
controlled trials with e-cigarettes show encouraging results in
terms of successful smoking cessation [44].
Surprisingly, our study showed the lowest average weight
(and BMI) in life-long non-smokers as well as in ex-smokers,
but this only in men. There was also no statistically signiﬁcant
difference in body fat percentage when directly comparing
smokers and non-smokers (excluding ex-smokers). Overall,
the highest average of body fat percentage as well as the
highest BMI was seen in ex-smokers, with this change driven
by males. As previously described, a moderate (4–10%) weight
gain in recent ex-smokers is not considered a deleterious or
beneﬁcial effect of smoking cessation [45]; and as this ﬁnding
was made in cohort studies, a moderate weight gain with
increasing age might be even desirable [46]. Needless to say,
one should be aware of what is referred to as reverse causality
(especially women smoking to lose weight) [47,48]. A common
biological basis for nicotine addiction and obesity has been
clearly demonstrated (single nucleotide polymorphismsshared by smokers and the obese in a large cohort of more
than 127,000 volunteers from Iceland) implying a stronger
association than simply the metabolic effect of nicotine on
metabolism or abstinence symptoms [49].
Surprisingly, as is evident from Figure 1 (‘‘Factors prevent-
ing smokers from quitting’’), only one ﬁfth of smokers declare
they do not want to quit (signiﬁcantly more often in men than
in women, 31.1% and 27.7%, respectively). However, 95% of the
smokers declared at least one quit attempt. The readiness to
quit ladder of Brno population is then shown in the (Figure 3).
In accordance with WHO M-POWER [50], our study supports
the need for exact tobacco use description including biochem-
ical validation in a randomly selected population, not available
in most countries.
A limitation of our study is the lower response rate of our
sample compared with other Czech post-MONICA study
regions. There may be two possible explications: no ﬁnancial
compensation provided to Brno volunteers participating in our
project and a low level of motivation of Brno citizens to have
their health status in a setting with good availability of health
care. Our response rate is not deﬁnitive yet. Other researchers
in Western countries consider response rates around 40%
acceptable. They think the fact that they had advance personal
contact with their volunteers seems to be crucial [51–53]. As is
evident from our own demographic pyramid, we had the
highest response rate among elderly women and the lowest
response rate among young men with a lower level of
education, who are less health-conscious. As demonstrated
by our pilot study with 325 volunteers (74% of women)
conducted in 2012 (unpublished data), monitoring of cardio-
vascular risk factors is deﬁnitely more popular among older
age groups and women. It should be noted that the majority
of our pilot male volunteers made their appointment
together with their wives. On the contrary, the youngest
generation is very difﬁcult to motivate to join any cross-
sectional surveys due to their workload, family require-
ments, no ﬁnancial motivation or simply absence of any
health problems.
We cannot compare ourselves with the State Health
Institute running annual nationwide surveys with more than
303 interviewers, producing a sample of 1481 volunteers aged
15–64. If subtracting the youngest age group (259 participants),
the remaining sample includes 1222 volunteers aged 25–64,
which is only one third bigger than our sample size
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 1 8 – e 1 2 7 e125(representing only one city). It should be underlined that the
previous Czech post-MONICA study had an exceptional
response rate of 60%, which is not often enough appreciated.
Conclusion: The prevalence of smoking in a randomly
selected population sample in the City of Brno remains very
high: the prevalence rates of smokers and ex-smokers were
26.70% and 19.88%, respectively. The self-reported incidence of
passive smoking was 34.01%. This publication provides
preliminary data on tobacco and electronic cigarette use in
a cross-sectional survey of the population of the city of Brno.
As the surveyed population aged 25–64 was randomly selected
and use of tobacco determined using a validated method, our
data can also be used to seek correlations between tobacco use
and other cardiovascular risk factors.
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